These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24516213)

  • 1. Cross-boundary cancer studies at the University of Tokyo: What we can do to overcome cancer.
    Kato M
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i48-53. PubMed ID: 24516213
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-boundary cancer studies at the University of Tokyo: Astellas in Asia: challenge for cancer.
    Nogimori M
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i60-64. PubMed ID: 24516216
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-boundary cancer studies at the University of Tokyo: Opening a path through research to the future of cancer treatment.
    Noda T
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i43-47. PubMed ID: 24516212
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-boundary cancer studies at the University of Tokyo: Oncology in Asian countries: clinical development challenges and opportunities.
    Rigaudy P
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i54-59. PubMed ID: 24516214
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-boundary cancer studies at the University of Tokyo: Measures to control cancer in Japan.
    Kakizoe T
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i38-42. PubMed ID: 24516211
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-boundary cancer studies at the University of Tokyo: Asia as a partner for Japan.
    Nishiyama M
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i32-37. PubMed ID: 24516210
    [No Abstract]   [Full Text] [Related]  

  • 7. Lecture No. 4 Cancer care in Asia from the perspective of latest developments in the US pharmaceutical industry.
    Eiki N
    Jpn J Clin Oncol; 2021 May; 51(12 Suppl 2):i17-i20. PubMed ID: 34002778
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-boundary cancer studies at the University of Tokyo: Food and cancer.
    Hattori Y
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i28-31. PubMed ID: 24516208
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross-boundary Cancer Studies at the University of Tokyo: View from the world of science and reason.
    Akaza H
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i3-5. PubMed ID: 24516209
    [No Abstract]   [Full Text] [Related]  

  • 10. Surviving cancer in Asia: cross-boundary cancer studies, University of Tokyo.
    Akaza H
    Jpn J Clin Oncol; 2021 May; 51(12 Suppl 2):i4-i6. PubMed ID: 34002789
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-boundary cancer studies at the University of Tokyo: The globalization of healthcare.
    Shibuya K
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i69-73. PubMed ID: 24516218
    [No Abstract]   [Full Text] [Related]  

  • 12. Cross-boundary cancer studies at the University of Tokyo: Surviving cancer in Asia: introduction.
    Akaza H; Kawahara N
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i1-2. PubMed ID: 24516204
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross-boundary cancer studies at the University of Tokyo: Shining a light in the darkness: what can we see?
    Sasakawa Y
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i74-77. PubMed ID: 24516219
    [No Abstract]   [Full Text] [Related]  

  • 14. Cross-boundary cancer studies at the University of Tokyo: View from the world of humanities.
    Kawahara N
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i6-7. PubMed ID: 24516215
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer charity sees success re-prioritizing industry's shelved compounds.
    Mullard A
    Nat Rev Drug Discov; 2014 May; 13(5):319-21. PubMed ID: 24781536
    [No Abstract]   [Full Text] [Related]  

  • 16. Lecture No. 6 Asia Health and Wellbeing Initiative (AHWIN) and cancer.
    Takemi K
    Jpn J Clin Oncol; 2021 May; 51(12 Suppl 2):i24-i27. PubMed ID: 34002790
    [No Abstract]   [Full Text] [Related]  

  • 17. Having "Skin in the Game" and Allowing Cross-Border Importation of Drugs to Lower High Prices of Cancer Drugs.
    Kantarjian H; Mathisen MS; Lipton JH
    JAMA Oncol; 2015 Sep; 1(6):729-30. PubMed ID: 26182331
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer megafunds with in silico and in vitro validation: accelerating cancer drug discovery via financial engineering without financial crisis.
    Yang X; Debonneuil E; Zhavoronkov A; Mishra B
    Oncotarget; 2016 Sep; 7(36):57671-57678. PubMed ID: 27275544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lecture No. 3 Current status and future outlook for collection of cancer-related data in Asia.
    Matsuda T
    Jpn J Clin Oncol; 2021 May; 51(12 Suppl 2):i14-i16. PubMed ID: 34002791
    [No Abstract]   [Full Text] [Related]  

  • 20. The new significance of UHC for cancer in Asia in the era of data-driven cancer research.
    Kawahara N
    Jpn J Clin Oncol; 2021 May; 51(12 Suppl 2):i50-i51. PubMed ID: 34002788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.